Tocilizumab and COVID-19: Timing of Administration and Efficacy

• Asıl Yazarlar: Emna Abidi (Yazar), Wasim S. El Nekidy (Yazar), Eman Alefishat (Yazar), Nadeem Rahman (Yazar), Georg A. Petroianu (Yazar), Rania El-Lababidi (Yazar), Jihad Mallat (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Elevated concentrations of interleukin-6 have been demonstrated to be an important key factor in COVID-19 host immune impairment. It represents an important prognostic factor of harm associated with COVID-19 infection by stimulating a vigorous proinflammatory response, leading to the so-called "...